Earnings Call to Discuss Results to be Conducted Thursday, May 23 at 8:00 am ET
Taro Pharmaceutical Industries Ltd. TARO announced today that it plans to release its financial results for year ended March 31, 2019, on Wednesday, May 22, 2019.
The Company will conduct an earnings call at 8:00 am ET on Thursday, May 23, 2019, where senior management will discuss the Company's performance and answer questions from participants.
The release will be accessible on Taro's website at www.taro.com.
Earnings Call (8:00 am ET on Thursday, May 23, 2019)
To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.
|
Summary of events |
||||||
| Event | Date and time | Telephone number/ website | ||||
| Earnings release | May 22, 2019 (AMC) | |||||
| Earnings conference call | May 23, 2019 | Participant Toll-Free Dial-In Number: +1 (844) 421-0601 | ||||
| 8:00 am ET | Participant International Dial-In Number: +1 (716) 247-5800 | |||||
| ID: 8698095 | ||||||
| Via audio webcast, details of which will be made available on www.taro.com | ||||||
| Replay of conference call | May 23, 2019 to | + 1 (855) 859-2056 or +1 (404) 537-3406 | ||||
| May 31, 2019 | ID: 8698095 | |||||
|
Via audio webcast playback, details of which will be made available on www.taro.com |
||||||
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company's website at www.taro.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190516005950/en/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
